Thousand Oaks, California
United States
73
2025-12-18
The entities that hold a legal rights for patent applications filed by inventor Chen Ning:
Ning Chen from Thousand Oaks, US has applied for patents for these inventions. The list has both pending applications and granted patents:
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#2 | 2025-10-02MACROCYCLIC COMPOUNDS AND METHODS OF USE
#3 | 2025-07-24MACROCYCLIC COMPOUNDS AND METHODS OF USE
#4 | 2025-06-05QUINAZOLINE COMPOUNDS AND USES THEREOF AS INHIBITORS OF MUTANT KRAS PROTEINS
#5 | 2025-04-17HETEROCYCLIC COMPOUNDS AND METHODS OF USE
#6 | 2025-02-20Heterocyclic Compounds and Methods of Use
#7 | 2025-02-20Heterocyclic Compounds and Methods of Use
#8 | 2025-01-30HETEROCYCLIC COMPOUNDS AND METHODS OF USE
#9 | 2024-12-19HETEROCYCLIC COMPOUNDS AND METHODS OF USE
#10 | 2024-09-05MACROCYCLIC COMPOUNDS AND METHODS OF USE
#11 | 2024-08-29INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME
#12 | 2024-02-15KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#13 | 2023-03-23SMARCA2-VHL DEGRADERS
#14 | 2022-12-15KRAS G12C inhibitors and methods of using the same
#15 | 2022-07-07Inhibitors of KRAS G12C and methods of using the same
#16 | 2022-06-09Substituted piperazines as KRAS G12C inhibitors
#17 | 2021-06-10HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE
#18 | 2020-07-231,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
#19 | 2020-07-02Inhibitors of KRAS G12C and methods of using the same
#20 | 2020-07-02Substituted oxazines as beta-secretase inhibitors
#21 | 2020-06-25Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
#22 | 2020-01-30KRAS G12C inhibitors and methods of using the same
#23 | 2019-12-12Substituted piperazines as KRAS G12C inhibitors
#24 | 2019-11-14KRAS G12C inhibitors and methods of using the same
#25 | 2019-11-07KRAS G12C inhibitors and methods of using the same
#26 | 2019-09-19Triazole phenyl compounds as agonists of the APJ receptor
#27 | 2019-09-12Triazole furan compounds as agonists of the APJ receptor
#28 | 2019-03-14Inhibitors of KRAS G12C and methods of using the same
#29 | 2018-11-08Triazole agonists of the APJ receptor
#30 | 2018-08-09Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
#31 | 2017-10-05Methods of treating heart failure
#32 | 2017-02-16Methods for preparing triazole agonists of the APJ receptor
#33 | 2017-02-16Intermediates for preparing triazole agonists of the APJ receptor
#34 | 2017-02-16Triazole agonists of the APJ receptor
#35 | 2017-02-16Triazole agonists of the APJ receptor
#36 | 2017-02-09Triazole agonists of the APJ receptor
#37 | 2017-02-09Intermediates for preparing triazole agonists of the APJ receptor
#38 | 2016-11-24Triazole agonists of the APJ receptor
#39 | 2015-10-29Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
#40 | 2014-09-04Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
#41 | 2013-08-29Heterobicyclic compounds
#42 | 2013-03-28Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
#43 | 2012-11-01PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS
#44 | 2011-07-07Gamma Secretase Modulators
#45 | 2011-06-30Pyrazine compounds as phosphodiesterase 10 inhibitors
#46 | 2011-06-30Pyrazine compounds as phosphodiesterase 10 inhibitors
#47 | 2010-09-16Bis-aryl amide compounds and methods of use
#48 | 2010-06-24Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
#49 | 2010-06-03Pyrazine compounds as phosphodiesterase 10 inhibitors
#50 | 2010-05-20Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
#51 | 2009-10-22VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
#52 | 2009-09-01Vanilloid receptor ligands and their use in treatments
#53 | 2009-08-06Vanilloid receptor ligands and their use in treatments
#54 | 2009-03-05PHOSPHODIESTERASE 10 INHIBITORS
#55 | 2009-02-26ISOQUINOLONE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS
#56 | 2008-12-25Di-amino-substituted heterocyclic compounds and methods of use
#57 | 2008-09-18Benzisoxazole and isoxazolo-pyridine compounds and method of use
#58 | 2007-11-15Substituted piperazines and methods of use
#59 | 2007-06-28Vanilloid receptor ligands and their use in treatments
#60 | 2007-03-29Bis-aryl amide compounds and methods of use
#61 | 2006-12-05Vanilloid receptor ligands and their use in treatments
#62 | 2006-10-03Substituted piperazinyl amides and methods of use
#63 | 2006-08-17Vanilloid receptor ligands and their use in treatments
#64 | 2006-05-30Vanilloid receptor ligands and their use in treatments
#65 | 2006-02-09Vanilloid receptor ligands and their use in treatments
#66 | 2005-12-15Vanilloid receptor ligands and their use in treatments
#67 | 2005-12-15Vanilloid receptor ligands and their use in treatments
#68 | 2005-12-08Vanilloid receptor ligands and their use in treatments
#69 | 2005-12-08Vanilloid receptor ligands and their use in treatments
#70 | 2005-12-01Vanilloid receptor ligands and their use in treatments
#71 | 2005-10-13Vanilloid receptor ligands and their use in treatments
#72 | 2005-08-18Vanilloid receptor ligands and their use in treatments
#73 | 2005-07-14Vanilloid receptor ligands and their use in treatments
167364 ⎘